Valbenazine Tosylate
CAS 1025504-55-6 5 FDA-DMF suppliersSmall Molecule
Overview
Valbenazine Tosylate is a prodrug of valbenazine, a small molecule used in the treatment of tardive dyskinesia, a disorder resulting in involuntary, repetitive body movements. It functions by selectively inhibiting the vesicular monoamine transporter 2 (VMAT2) leading to decreased uptake of neurotransmitters into synaptic vesicles.
Therapeutic areas
NeurologyPsychiatry
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.